Compounds > alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and vanoxerine

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with vanoxerine in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Studies
(vanoxerine)		Trials
(vanoxerine)		Recent Studies (post-2010) (vanoxerine)
9012556593

Protein Interaction Comparison

ProteinTaxonomyalpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (IC50)vanoxerine (IC50)
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.5098
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.0103
Sodium-dependent serotonin transporterHomo sapiens (human)1.5513
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.0969
Small conductance calcium-activated potassium channel protein 2Rattus norvegicus (Norway rat)0.073
Small conductance calcium-activated potassium channel protein 3Rattus norvegicus (Norway rat)0.073
Small conductance calcium-activated potassium channel protein 1Rattus norvegicus (Norway rat)0.073
Sodium-dependent dopamine transporter Homo sapiens (human)0.0424
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.022
TransporterRattus norvegicus (Norway rat)0.114

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Booth, RG; Brown, RL; Bucholtz, EC; Tropsha, A; Wyrick, SD1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and vanoxerine

ArticleYear
Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
    Journal of medicinal chemistry, 1999, Aug-12, Volume: 42, Issue:16

    Topics: Animals; Binding Sites; Binding, Competitive; Brain; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ligands; Models, Molecular; Pyrilamine; Radioligand Assay; Structure-Activity Relationship; Tetrahydronaphthalenes

1999